Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer

Journal article

Peer reviewed

Sean R O'Neil, Garrett A Weber, Dustin A Deming, Mark E Burkard, Paraic A Kenny, Craig S Richmond and Benjamin M Parsons

JCO precision oncology, Vol.7(7), pp.e2300174-e2300174

07/2023

DOI: 10.1200/PO.23.00174

PMID: 37487149

View Online

no abstract | case reports

Adaptor Proteins, Signal Transducing

Anilides

Crizotinib

Golgi Matrix Proteins

Humans

Neoplasms

Protein-Tyrosine Kinases

Proto-Oncogene Proteins

Title: Subtitle: Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer
Creators: Sean R O'Neil - Gundersen Health System
Garrett A Weber - Gundersen Health System
Dustin A Deming - University of Wisconsin–Madison
Mark E Burkard - University of Wisconsin–Madison
Paraic A Kenny - Gundersen Health System
Craig S Richmond - Gundersen Health System
Benjamin M Parsons - Gundersen Health System
Resource Type: Journal article
Publication Details: JCO precision oncology, Vol.7(7), pp.e2300174-e2300174
DOI: 10.1200/PO.23.00174
PMID: 37487149
ISSN: 2473-4284
eISSN: 2473-4284
Language: English
Date published: 07/2023
Academic Unit: Internal Medicine
Record Identifier: 9984701247202771

5 Record Views